Compare MLP & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MLP | CDXS |
|---|---|---|
| Founded | 1909 | 2002 |
| Country | United States | United States |
| Employees | 20 | N/A |
| Industry | Real Estate | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 307.8M | 256.3M |
| IPO Year | 2010 | 2008 |
| Metric | MLP | CDXS |
|---|---|---|
| Price | $15.17 | $1.36 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $6.14 |
| AVG Volume (30 Days) | 10.7K | ★ 669.4K |
| Earning Date | 11-13-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.82 |
| EPS | N/A | ★ N/A |
| Revenue | $19,457,000.00 | ★ $138,590,000.00 |
| Revenue This Year | N/A | $4.97 |
| Revenue Next Year | N/A | $18.69 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 68.24 | 32.30 |
| 52 Week Low | $13.84 | $0.96 |
| 52 Week High | $19.92 | $2.98 |
| Indicator | MLP | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 32.12 | 44.00 |
| Support Level | $15.14 | $1.27 |
| Resistance Level | $16.45 | $1.77 |
| Average True Range (ATR) | 0.51 | 0.07 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 44.71 | 44.81 |
Maui Land & Pineapple Co Inc is a landholding and operating parent company that owns land and commercial property on the island of Maui, Hawaii. The Company puts its assets into productive use by planning, managing, developing, and selling residential, resort, commercial, agricultural, and industrial real estate. Its segments include land development and sales, which cover land planning, entitlement, development, construction, and sales of land assets; leasing, which generates revenue from real property leasing, license fees and royalties, and includes maintenance of real estate assets, conservation activities, and management of water systems in West and Upcountry Maui; and resort amenities, which include a membership program offering benefits within the Kapalua Resort.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.